The petition with the US DEA is aiming to remove dual orexin receptor antagonist medications from the Controlled Substances Act due to negligible potential for abuse.
Over the past decade, suicide rates decreased by almost 20% in Europe, but there was high variability between counties and by gender, a large analysis shows.